| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789962 | Urologic Oncology: Seminars and Original Investigations | 2018 | 6 Pages |
Abstract
We demonstrate that for surveillance to be superior to treatment with BEP Ã1 or RPLND, the orchiectomy cure rate must be at least 82%, which is not expected in a patient population with high-risk CS1 NSGCT.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Svetlana M.D., Clayton M.D., Alicia M.D., M.P.H., Kelvin A. M.D., Ph.D.,